By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere announced on Tuesday after the close of the market that it has settled a patent dispute with Eppendorf for $4 million, and as a result acquired certain patents and the patent rights on a global basis.

Eppendorf also received a limited license to service its existing customers as part of the settlement. Licenses previously issued by Eppendorf to other companies and that relate to the purchased patents and patent rights remain in effect.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.